HCA Healthcare (NYSE:HCA – Free Report) had its price objective hoisted by Wells Fargo & Company from $365.00 to $395.00 in a research note released on Tuesday morning, Benzinga reports. Wells Fargo & Company currently has an equal weight rating on the stock.
HCA has been the topic of several other research reports. Royal Bank of Canada lifted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Barclays lifted their target price on shares of HCA Healthcare from $376.00 to $396.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Truist Financial lifted their target price on shares of HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, August 19th. Morgan Stanley started coverage on shares of HCA Healthcare in a research report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 price target on the stock. Finally, Leerink Partners upped their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and four have issued a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $367.15.
View Our Latest Research Report on HCA
HCA Healthcare Trading Down 0.6 %
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion during the quarter, compared to analysts’ expectations of $17.05 billion. During the same quarter last year, the company posted $4.29 earnings per share. The firm’s revenue was up 10.3% compared to the same quarter last year. Equities research analysts predict that HCA Healthcare will post 22.51 earnings per share for the current year.
Insider Transactions at HCA Healthcare
In related news, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total value of $1,440,800.00. Following the completion of the sale, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $360.20, for a total transaction of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 17,202 shares of company stock worth $6,407,273 over the last ninety days. 1.60% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the business. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter worth $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare during the second quarter worth $28,000. Bangor Savings Bank lifted its position in shares of HCA Healthcare by 112.5% during the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares in the last quarter. GPS Wealth Strategies Group LLC lifted its position in shares of HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare in the second quarter valued at $33,000. 62.73% of the stock is owned by institutional investors and hedge funds.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also
- Five stocks we like better than HCA Healthcare
- What Are Dividends? Buy the Best Dividend Stocks
- How Verizon Could Offer Stress-Free Double-Digit Returns in 2025
- How to Choose Top Rated Stocks
- Can Roche Challenge Lilly and Novo in the Weight Loss Market?
- 3 REITs to Buy and Hold for the Long Term
- Roblox Stock: Key Metrics Surge, Is This the Perfect Entry?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.